Keith Fandrick

Chief Operating Officer at IRULYA THERAPEUTICS INC.

Consumer Services

Health Technology

Profile

Dr. Keith R.
Fandrick is a Chief Operating Officer at IRulya Therapeutics, Inc. Dr. Fandrick was previously employed as a Chief Operating Officer by OrphAI Therapeutics, Inc. He received his undergraduate degree from the University of California, a graduate degree from Harvard University, an MBA from Kenan-Flagler Business School and a doctorate degree from Harvard University.

Keith Fandrick active positions

Companies	Position	Start
IRULYA THERAPEUTICS INC.	Chief Operating Officer	08/10/2026

All active positions of Keith Fandrick

Former positions of Keith Fandrick

Companies	Position	End
AI Therapeutics, Inc. AI Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on developing therapies for pulmonary diseases	Chief Operating Officer	-

See the detail of Keith Fandrick's experience

Education of Keith Fandrick

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Keith Fandrick's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	5
Harvard University Harvard University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Kenan-Flagler Business School Kenan-Flagler Business School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of California University of California Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Quince Therapeutics, Inc. Quince Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops drugs for the treatment of central nervous system disorders and Alzheimer’s diseases	Health Technology
AI Therapeutics, Inc. AI Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on developing therapies for pulmonary diseases	Health Technology